During the past decade, Florida Institute For Clinical Research, LLC conducted 11 clinical trials. In the 10-year time frame, 11 clinical trials started and 7 clinical trials were completed, i.e. on average, 63.6% percent of trials that started reached the finish line to date. In the past 5 years, 7 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Florida Institute For Clinical Research, LLC" #1 sponsor was "AstraZeneca" with 2 trials, followed by "Enanta Pharmaceuticals, Inc" with 2 trials sponsored, "Gilead Sciences" with 2 trials sponsored, "Société des Produits Nestlé (SPN)" with 2 trials sponsored and "Sunovion" with 2 trials sponsored. Other sponsors include 5 different institutions and companies that sponsored additional 13 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Florida Institute For Clinical Research, LLC" #1 collaborator was "Bristol-Myers Squibb" with 2 trials as a collaborator, "Iqvia Pty Ltd" with 2 trials as a collaborator and "PPD" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "Florida Institute For Clinical Research, LLC" are "Chronic Obstructive Pulmonary Disease" (3 trials), "Attention Deficit Hyperactivity Disorder" (2 trials), "Insomnia" (2 trials), "Type 2 Diabetes" (2 trials) and "Type 2 Diabetes Mellitus" (2 trials). Many other conditions were trialed in "Florida Institute For Clinical Research, LLC" in a lesser frequency.

Most popular intervention types in "Florida Institute For Clinical Research, LLC" are "Drug" (16 trials), "Other" (4 trials), "Behavioral" (2 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (10 trials), "Dapagliflozin" (2 trials), "Diet" (2 trials), "EDP-938" (2 trials) and "Ensifentrine" (2 trials). Other intervention names were less common.

The vast majority of trials in "Florida Institute For Clinical Research, LLC" are 20 trials for "All" genders.

Currently, there are NaN active trials in "Florida Institute For Clinical Research, LLC". undefined are not yet recruiting, 3 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 14 completed trials in Florida Institute For Clinical Research, LLC, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Florida Institute For Clinical Research, LLC, 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 14 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 3 trials that are defined as “Not Applicable".